Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLF5 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
mRNA | FNIP2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | GKAP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | ZKSCAN3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | ROPN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | ANO1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | SEC61G | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | THBD | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | CAND2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ZNF709 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |